Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art.
View/ Open
Date
2019-08-01ICR Author
Author
Perez-Lopez, R
Tunariu, N
Padhani, AR
Oyen, WJG
Fanti, S
Vargas, HA
Omlin, A
Morris, MJ
de Bono, J
Koh, D-M
Type
Journal Article
Metadata
Show full item recordAbstract
The management of advanced prostate cancer has changed substantially with the availability of multiple effective novel treatments, which has led to improved disease survival. In the era of personalized cancer treatments, more precise imaging may help physicians deliver better care. More accurate local staging and earlier detection of metastatic disease, accurate identification of oligometastatic disease, and optimal assessment of treatment response are areas where modern imaging is rapidly evolving and expanding. Next-generation imaging modalities, including whole-body MRI and molecular imaging with combined PET and CT and combined PET and MRI using novel radiopharmaceuticals, create new opportunities for imaging to support and refine management pathways in patients with advanced prostate cancer. This article demonstrates the potential and challenges of applying next-generation imaging to deliver the clinical promise of treatment breakthroughs.
Collections
Subject
Prostate
Humans
Prostatic Neoplasms
Positron-Emission Tomography
Magnetic Resonance Imaging
Neoplasm Staging
Follow-Up Studies
Male
Multimodal Imaging
Positron Emission Tomography Computed Tomography
Research team
Prostate Cancer Targeted Therapy Group
Translational Molecular Imaging
Language
eng
License start date
2019-08
Citation
Radiology, 2019, 292 (2), pp. 273 - 286
Publisher
RADIOLOGICAL SOC NORTH AMERICA (RSNA)